Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China Blog Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…CertaraAugust 7, 2020
Conventional & Mechanistic IVIVC: Complementary or Clashing Methods? Blog Conventional & Mechanistic IVIVC: Complementary or Clashing Methods? An IVIVC (in vitro-in vivo correlation) is a mathematical relationship that predicts key pharmacokinetic parameters…CertaraFebruary 9, 2016
Common Misconceptions About Computer System Validation Blog Common Misconceptions About Computer System Validation Drug development professionals frequently use computer systems to help them understand the pharmacokinetics (PK) and…CertaraJanuary 28, 2015
Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies Blog Using Modeling and Simulation to Quantify the PK of an Anti-HIV Drug for Babies As a scientist at Certara and proud Dad to my three kids, pediatric drug development…CertaraJanuary 15, 2015
Understanding Steady State Pharmacokinetics BlogKnowledge Base Understanding Steady State Pharmacokinetics Register for our July 10 webinar and discover fast, flexible, frictionless PK/PD workflows with Phoenix…CertaraNovember 25, 2013
Calculating Urine PK Parameters BlogKnowledge Base Calculating Urine PK Parameters Pharmacokinetic analysis normally focuses on systemic exposure to a drug; however, much can be learned…CertaraDecember 6, 2012
The Difference Between Vd and Vss BlogKnowledge Base The Difference Between Vd and Vss There are many terms used to represent volume of distribution, but two common ones are…CertaraMarch 31, 2011
Understanding Volume of Distribution BlogKnowledge Base Understanding Volume of Distribution Register for our July 10 webinar and discover fast, flexible, frictionless PK/PD workflows with Phoenix…CertaraJune 5, 2010